WWM
NPCE icon

Western Wealth Management’s Neuropace NPCE Stock Holding History

Western Wealth Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Hold
22,950
– – 0.01% 797
2025
Q4 		$354K Sell
22,950
-50
-0.2% -$669 0.02% 612
2025
Q3 		$237K Buy
+23,000
New +$217K 0.01% 683

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Western Wealth Management's NPCE Position: Q1 2026 in Review

Western Wealth Management held its Neuropace (NPCE) position steady in Q1 2026 at 22,950 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #797.

Western Wealth Management first reported a position in NPCE in Q3 2025 and has held it in 3 quarters since. The position peaked at $354K in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Western Wealth Management held 22,950 shares of Neuropace worth $302K as of Q1 2026.
  • Western Wealth Management left its Neuropace share count unchanged in Q1 2026.
  • Neuropace made up 0.01% of Western Wealth Management's portfolio in Q1 2026, its #797 holding.
  • Western Wealth Management first reported a position in Neuropace in Q3 2025 and has held it in 3 quarters since.
  • Western Wealth Management's Neuropace position peaked at $354K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.